2025
Patent Granted in China (miRNA as biomarker for Parkinson's disease)
Selected for R&D project by the Ministry of SMEs and Startups
2024
Selected for R&D project by the Ministry of SMEs and Startups
Completion of Startup Leap Package Support Project
Selected for Deep-Tech TIPS project (Fast track) by the Ministry of SMEs and Startups
2023
Selected for Startup Leap Package Support Project project by the Ministry of SMEs and Startups
HQ & Corporate Research Institute Relocation (Seongdong-gu Knowledge Industry Center, Seoul)
Attracted strategic investment from Asan Pharm
Received the BEST Award for Diagnostics & Laboratory Equipment at the MEDITEK Innovation Awards.
2022
Patent Granted in US, Japan (miRNA as biomarker for Parkinson's disease)
Signed MOU with Dong-A ST
Attracted angel investment
Selected as a Promising Leading Company in Seoul's 4 Future Growth Industries
Completion of R&D project by the Ministry of SMEs and Startups
2021
Selected for an R&D project (1) by Korea Health Industry Development Institute
Selected for an R&D project by the Ministry of SMEs and Startups
Selected for an R&D project (2) by Korea Health Industry Development Institute
Completion of R&D project (1) by Korea Health Industry Development Institute
2020
Attracted financial investment from Korea Venture Investment Corp .
Corporate Research Institute established
Securing additional research space in Seoul Biohub
Successfully completed R&D project by the Ministry of Science and ICT
2019
Selected as a resident company of Seoul Biohub
Attracted angel investment
Selected for R&D project by the Ministry of Science and ICT
Venture company certification
